73 results
Page 2 of 4
8-K
EX-2.2
7fui 8hbne
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
6hu8jxceoex7yj64 a5p
18 May 22
Termination of a Material Definitive Agreement
4:06pm
8-K
EX-10.1
gngxbk4 io
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
nyyq3rlq3pzkl1
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-1.1
3jwvhteo2iu gjg4
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K/A
EX-99.3
56tucmr7o0
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.1
987 7ymqq7
3 Feb 21
Other Events
4:59pm
D
iwpfoxbai 3y9
6 Jan 21
$33.6M in equity, sold $33.6M, 16 investors
5:28pm
8-K
EX-10.1
i01nz qy9omc869he
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
969jo5fm
15 Dec 20
Business combination disclosure
7:32am
424B3
j8ibhy vf0k7
12 Nov 20
Prospectus supplement
6:08am